Hillhurst Biopharmaceuticals, Inc.
0 followers
Hillhurst’s proprietary GLASS platform enables novel uses of therapeutic gases that, up until now, have been limited by inhaled delivery. We’ve developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson’s disease, and acute pai... Read more
Org chart
Andrew Gomperts
President and CEO
Andrew Gomperts
Collapse
Onne Ganel
Business Development Lead
Jeffrey Friedman
Board Member
Alonso Guzman
Consultant: Regulatory Affairs And Operations, US Submission Management
